Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology.
Psychopharmacol Bull
; 54(3): 97-99, 2024 Jul 08.
Article
de En
| MEDLINE
| ID: mdl-38993658
ABSTRACT
NTX is FDA-approved for opiate and alcohol use disorders as anti-craving agent. It has been used successfully off-label in other psychiatric indications. Here, we shed some light on these while examining the extant evidence.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Naltrexone
/
Antagonistes narcotiques
Limites:
Animals
/
Humans
Langue:
En
Journal:
Psychopharmacol Bull
Année:
2024
Type de document:
Article
Pays de publication:
États-Unis d'Amérique